You are on page 1of 2

Unit A 4-B Jakka Plaza Mall, 8288 Dr. A.

Santos Avenue, Sucat, Parañaque

Lab Number: 2215062040 Date of Request: 2022-09-12


Name : MOLINA, MARCELIANO JR VIRAY Date of Procedure: 2022-09-13
Age: 64 Sex: MALE HT: 176 cm WT: 70.5 kg BSA: 1.86 HR: 60 Date of Result: 2022-09-13
Physician: TOPACIO, GRACITA O M.D. DVD No. : HPS-T122

2D ECHOCARDIOGRAM
Parameter Result Normal Range Parameter Result Normal Range Parameter Result Normal Range
F: 3.8 - 5.2 cm F: 56 - 104 mL
LVEDD 5.5 LVEDV 147 RV (mid) 2.9 2.7 - 3.5 cm
M: 4.2 - 5.8 cm M: 67-155 mL
F: 2.2 - 3.5 cm F: 19 - 49 mL
LVESD 3.9 LVESV 64 RA (R-L) 3.9 2.9 - 4.5 cm
M: 2.5 - 4.0 cm M: 22 - 58 mL

F: 2.4 – 3.2 cm/m²


SV 83 >65 mL RA / BSA 2.1 1.7 – 2.5 cm/m²
LVEDD / BSA 3.0 M: 2.2 – 3.1 cm/m² F: 2.7 - 3.8 cm
CO - >4.5L/min LA (A-P) 3.6
M: 3.0 - 4.0 cm
LVESD / BSA 2.1 1.4 – 2.1 cm/m² CI - 2.4 – 4.2 L/min/m² LA/BSA 1.9 1.5 – 2.3 cm/m²
F: 0.6 -0.9 cm
IVSD 1.2 EF(M-Mode) 56 >55% LAVI 29 <34 mL/m²
M: 0.6 - 1.0 cm

IVSS 1.5 LVOT 1.8 1.8 - 2.4 cm


EF(Simpson's) - >55%
F: 0.6 -0.9 cm AV op. - 1.5 - 2.1 cm
PWD 0.6 M: 0.6 - 1.0 cm
FS 30 27-45% - 24-43% Aorta 2.6
F: 2.3 + 0.28 cm
PWS 1.1 EPSS 1.3 <0.7 cm Annulus 1.8 M: 2.6 + 0.3 cm

Sinus of F: 3.0 + 0.3 cm


LVET 272 265 - 325 m/sec 3.0
F: 43 – 95 g/m² Valsalva M: 3.4 + 0.3 cm
LVMI 118 M: 49 – 115 g/m² F: 2.3 + 0.2 cm
GLS - >18% ST Junction 3.0
M: 2.9 + 0.3 cm
F: 2.7 + 0.4 cm
RWT 0.22 0.24 - 0.42 cm RVFAC - > 35% Ascending 3.1 M: 3.0 + 0.4 cm

MV Annulus 2.8 1.9 - 3.4 cm TAPSE 18 > 17 mm Arch - 2.2 - 3.6 cm


TV Annulus 2.7 1.2 - 2.8 cm RVWT - < 0.5 cm MPA 2.0 1.5 - 2.1
IVC Diameter - 1.2 - 1.7 cm
PV Annulus 2.3 1.7 - 2.3 cm RVOT 2.5 2.5 - 2.9 cm
IVC Collapse - >50%

SPECTRAL AND COLOR FLOW DOPPLER


Hemodynamic Analysis Regurgitation
Peak Gradient
Velocity (m/sec) VTI (cm) Valve Area (cm²) Jet Area Vc (cm)
(mmHg)
LVOT 0.70 1.97
Aortic Valve 1.22 5.99
Mitral Valve 0.95/0.83 3.63/2.75 45
Tricuspid Valve 0.66/0.44 1.75/0.79
Pulmonic Valve 0.81 2.62 11
Pulmonary Artery
PAT 144 RVAT sPAP (TR Jet) mmHg mPAP mmHg
Pressure

Page 1 of 2
Unit A 4-B Jakka Plaza Mall, 8288 Dr. A. Santos Avenue, Sucat, Parañaque

Lab Number: 2215062040 Date of Request: 2022-09-12


Name : MOLINA, MARCELIANO JR VIRAY Date of Procedure: 2022-09-13
Age: 64 Sex: MALE HT: 176 cm WT: 70.5 kg BSA: 1.86 HR: 60 Date of Result: 2022-09-13
Physician: TOPACIO, GRACITA O M.D. DVD No. : HPS-T122

DIASTOLIC FUNCTION

Pulmonary Venous Velocity Mitral Inflow Mitral Annulus Velocity

Normal Normal Normal


Parameter Result Parameter Result Parameter Result Range Parameter Result Range
Range

Systolic 0.65 m/sec E Wave DT 211 160 - 230 Lat E’ 0.05 m/sec > 0.10 Med E’ 0.07 m/sec > 0.07
m/sec m/sec m/sec

Diastolic 0.39 m/sec IVRT 116 60 - 90 Lat A’ 0.07 m/sec Med A’ 0.13 m/sec
m/sec

S/D ratio 1.68 A wave m/sec E/E Ratio < 14


duration

Ar Duration 78 m/sec A dur - A m/sec E/A Ratio


dur

Ar Velocity 0.30 m/sec

Molina Marcelino
Normal left ventricular cavity size, increased left ventricular mass index of 118 g/m2 with normal relative wall thickness of 0.22 with mild
hypokinesia of the posterior wall and inferior septum
Normal left atrium without thrombus
Normal right ventricular size and resting systolic function; normal right atrium
Thickened aortic valve cusps without restriction in motion
Structurally normal mitral, tricuspid and pulmonic valves
Normal main pulmonary artery and aortic root dimension
No pericardial effusion nor vegetation
Mild tricuspid and pulmonic regurgitation
Moderate mitral regurgitation
Normal pulmonary artery systolic pressure

Conclusion:

Eccentric left ventricular hypertrophy (indexed to BSA) with wall motion abnormality as described with preserved resting systolic function
Normal left atrium with no apparent thrombus
Aortic valve sclerosis
Mild tricuspid regurgitation
Moderate mitral regurgitation
Normal pulmonary artery pressure with pulmonic regurgitation

Cardiologist - Echocardiographer

The above 2D Echo/Doppler is a subjective medical opinion only based on the objective 2D Echo/Doppler finding and should be correlated with the clinical,
biochemical, microbiological, and other parameters before it can be used as a basis for management.

Page 2 of 2

You might also like